Pharmacokinetic and drug-food interaction trial to evaluate abuse-resistant hydrocodone/paracetamol formulated with Aversion Technology.

Trial Profile

Pharmacokinetic and drug-food interaction trial to evaluate abuse-resistant hydrocodone/paracetamol formulated with Aversion Technology.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2014

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 Sep 2014 Preliminary results published in an Acura Pharmaceuticals media release.
    • 29 Sep 2014 Primary endpoint (Blood concentrations; bioequivalence in fed and fasted states) has been met, according to an Acura Pharmaceuticals media release.
    • 29 Sep 2014 Status changed from planning to completed, according to an Acura Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top